DNA X, Inc. $SONM
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Telephone & Telegraph Apparatus
- Headquarters
- San Diego, CA
- Fiscal year end
- December 31
- Shares outstanding
- 1,488,268 [10-Q 2026-08-19]
What the company doesAI summary of filing
DNA X, Inc. operates a cryptocurrency trading platform at www.dnax.us that allows individual traders worldwide to buy, sell, and swap cryptocurrencies, as well as to execute automated trading strategies. The company generates revenue from commissions and fees on user trading activity and does not take custody of customer assets. The company acquired its trading platform in December 2025 and is currently operating on a limited basis while developing new products such as cryptocurrency lending and staking services; it is pre-revenue or early-stage revenue-generating, with the independent auditor noting substantial doubt about the company's ability to continue as a going concern. [10-K 2026-04-15]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | $5.09M | −$5.47M | $900.0K | [10-Q 2026-08-19] |
| FY ended Dec 2025 | — | −$20.66M | −$23.53M | $1.30M | [10-K 2026-04-15] |
| FY ended Dec 2024 | $58.30M | −$33.65M | −$8.49M | $5.34M | [10-K 2025-03-31] |
- Quarterly cash burn
- −$2.73M
- Cash runway Estimate
- ~1 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2025-04-21 | 9,193,583 | [10-K/A 2025-04-29] |
| 2025-05-07 | 9,201,563 | [10-Q 2025-05-12] |
| 2025-08-01 | 17,738,905 | [10-Q 2025-08-08] |
| 2025-10-28 | 1,028,693 | [10-Q 2025-10-31] |
| 2026-03-27 | 1,488,268 | [10-K 2026-04-15] |
| 2026-04-21 | 1,488,268 | [10-K/A 2026-04-30] |
| 2026-05-14 | 1,488,268 | [10-Q 2026-05-20] |
| 2026-08-18 | 1,488,268 | [10-Q 2026-08-19] |
- Shelf registration
- S-1 filed 2025-09-29; declared effective 2026-06-11 [S-1 2025-09-29]
Listing status
Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-05-27. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-05-27 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-05-27] |
| 2025-10-20 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-10-20] |
| 2025-08-27 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-08-27] |
| 2025-08-14 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-08-14] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-02-09 | Crolius Clayton | grant | 35,000 | — | [4 2026-02-10] |
| 2026-02-09 | Mulica Michael C | grant | 50,000 | — | [4 2026-02-10] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-31 | 8-K | Other events |
| 2026-08-27 | 8-K | Director or officer change |
| 2026-08-19 | 10-Q | Quarterly report |
| 2026-08-14 | NT 10-Q | Notice of late quarterly report |
| 2026-08-13 | 8-K | Unregistered sale of equity; Other events |
| 2026-08-13 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-09 | 8-K | Unregistered sale of equity; Change to security holder rights; Charter, bylaws or fiscal year change |
| 2026-07-02 | 8-K | Material agreement entered; Unregistered sale of equity; Change to security holder rights |
| 2026-06-04 | 8-K | Material agreement terminated |
| 2026-05-27 | 8-K | Material agreement entered; New financial obligation; Listing notice or transfer |
| 2026-05-20 | 10-Q | Quarterly report |
| 2026-05-20 | 8-K | Results of operations |
Alerts for $SONM
Email me when DNA X, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.